Synaptogenix Stock Buy Hold or Sell Recommendation
| SNPX Stock | USD 2.72 0.01 0.37% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Synaptogenix is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Synaptogenix given historical horizon and risk tolerance towards Synaptogenix. When Macroaxis issues a 'buy' or 'sell' recommendation for Synaptogenix, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Synaptogenix Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide. In addition, we conduct extensive research on individual companies such as Synaptogenix and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Synaptogenix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Synaptogenix |
Execute Synaptogenix Buy or Sell Advice
The Synaptogenix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Synaptogenix. Macroaxis does not own or have any residual interests in Synaptogenix or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Synaptogenix's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Synaptogenix Trading Alerts and Improvement Suggestions
| Synaptogenix generated a negative expected return over the last 90 days | |
| Synaptogenix has high historical volatility and very poor performance | |
| Synaptogenix has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (6.04 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Synaptogenix currently holds about 28.75 M in cash with (5.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.2, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Synaptogenix Returns Distribution Density
The distribution of Synaptogenix's historical returns is an attempt to chart the uncertainty of Synaptogenix's future price movements. The chart of the probability distribution of Synaptogenix daily returns describes the distribution of returns around its average expected value. We use Synaptogenix price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Synaptogenix returns is essential to provide solid investment advice for Synaptogenix.
| Mean Return | -0.26 | Value At Risk | -8.05 | Potential Upside | 10.33 | Standard Deviation | 5.35 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Synaptogenix historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Synaptogenix Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Synaptogenix or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Synaptogenix's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Synaptogenix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.37 | |
β | Beta against Dow Jones | 0.83 | |
σ | Overall volatility | 5.35 | |
Ir | Information ratio | -0.07 |
Synaptogenix Volatility Alert
Synaptogenix exhibits very low volatility with skewness of -0.13 and kurtosis of 1.93. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Synaptogenix's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Synaptogenix's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Synaptogenix Fundamentals Vs Peers
Comparing Synaptogenix's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Synaptogenix's direct or indirect competition across all of the common fundamentals between Synaptogenix and the related equities. This way, we can detect undervalued stocks with similar characteristics as Synaptogenix or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Synaptogenix's fundamental indicators could also be used in its relative valuation, which is a method of valuing Synaptogenix by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Synaptogenix to competition |
| Fundamentals | Synaptogenix | Peer Average |
| Return On Equity | -0.075 | -0.31 |
| Return On Asset | -0.14 | -0.14 |
| Current Valuation | (18.08 M) | 16.62 B |
| Shares Outstanding | 1.36 M | 571.82 M |
| Shares Owned By Insiders | 1.94 % | 10.09 % |
| Shares Owned By Institutions | 0.29 % | 39.21 % |
| Number Of Shares Shorted | 5.46 K | 4.71 M |
| Price To Book | 0.29 X | 9.51 X |
| EBITDA | (8.31 M) | 3.9 B |
| Net Income | (6.04 M) | 570.98 M |
| Cash And Equivalents | 28.75 M | 2.7 B |
| Cash Per Share | 4.20 X | 5.01 X |
| Total Debt | 5.53 M | 5.32 B |
| Current Ratio | 47.22 X | 2.16 X |
| Book Value Per Share | 14.99 X | 1.93 K |
| Cash Flow From Operations | (5.17 M) | 971.22 M |
| Short Ratio | 0.17 X | 4.00 X |
| Earnings Per Share | 10.27 X | 3.12 X |
| Target Price | 14.0 | |
| Number Of Employees | 5 | 18.84 K |
| Beta | 1.43 | -0.15 |
| Market Capitalization | 4.07 M | 19.03 B |
| Total Asset | 31.11 M | 29.47 B |
| Retained Earnings | (33.61 M) | 9.33 B |
| Working Capital | 26.26 M | 1.48 B |
| Net Asset | 31.11 M |
Note: Acquisition by Tuchman Alan J of 112000 shares of Synaptogenix subject to Rule 16b-3 [view details]
Synaptogenix Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Synaptogenix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Synaptogenix Buy or Sell Advice
When is the right time to buy or sell Synaptogenix? Buying financial instruments such as Synaptogenix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Synaptogenix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Crypto And Gold Thematic Idea Now
Crypto And Gold
Assets that cancel away each other volatility by providing diversification into gold investment combined with digital assets. The Crypto And Gold theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Crypto And Gold Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Synaptogenix Stock Analysis
When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.